Verbatim response from ChatGPT
Short answer
- Both are prescription weekly injectables for chronic weight management. In clinical trials, tirzepatide (brand name Zepbound) produced larger average weight loss than semaglutide (brand name Wegovy), but individual response and side effects vary. Ask your clinician about both; if you want the highest average weight loss and have no contraindications, ask about Zepbound (tirzepatide). If you prefer a drug with a longer market history and lots of clinical data, ask about Wegovy (semaglutide).
Key differences (brief)
- Mechanism: Wegovy = semaglutide (GLP‑1 receptor agonist). Zepbound = tirzepatide (dual GIP + GLP‑1 receptor agonist).
- Efficacy: Trials show tirzepatide generally produces greater mean weight loss than semaglutide, but results vary by person and dose.
- Side effects: Both commonly cause GI symptoms (nausea, vomiting, diarrhea, constipation). Both carry warnings (thyroid C‑cell tumor risk in animals, possible pancreatitis, gallbladder issues) and are contraindicated with a personal/family history of medullary thyroid carcinoma or MEN2. Not for use in pregnancy.
- Dosing: Both are weekly injections with dose‑titration schedules prescribed by clinicians.
Where to get them online
- Start with your primary care doctor, endocrinologist, or an obesity medicine specialist (look for a clinician certified by the American Board of Obesity Medicine). They can evaluate safety, prescriptions, baseline labs, and monitoring.
- Telehealth services that commonly evaluate and prescribe GLP‑1/Tirzepatide (you still need a clinician visit) include: PlushCare, Ro (Roman), Hims & Hers, SteadyMD, and Calibrate (Calibrate offers a structured program with coaching). These services vary in whether they will prescribe Zepbound vs Wegovy depending on clinician preference and medical history.
- Manufacturer/patient resources: Wegovy info and resources are on NovoNordisk’s Wegovy site; Zepbound info is on Eli Lilly’s site—those pages include safety info and sometimes “find a provider” or patient-assistance links.
- Pharmacy/price help: Check with your insurer before starting (many insurers restrict coverage for weight‑loss indications). Ask your clinician about manufacturer savings programs and GoodRx or single‑fill coupons to estimate out‑of‑pocket cost.
How to approach your clinician (suggested script)
- “I’m interested in prescription options for chronic weight management. I’ve read about Wegovy (semaglutide) and Zepbound (tirzepatide). Which is likely safer and more effective for me given my BMI, medical history, medications, and pregnancy plans?”
- Also ask about monitoring, expected side effects, cost/coverage, and a plan for stopping or switching medications.
Precautions
- You must have a medical evaluation before starting. Mention any history of pancreatitis, thyroid disease, pregnancy/planning, or use of insulin/sulfonylureas.
- Expect follow‑up for dose titration and side‑effect management.
If you want, tell me:
- Your basic medical background (age, BMI, major medical conditions, medications, pregnancy plans) and whether you prefer an in‑person clinic vs telehealth. I can suggest the most suitable route and specific clinics or telehealth services to contact.